BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 573695)

  • 1. Behavioral changes produced in the cat by acute and chronic morphine injection and naloxone precipitated withdrawal.
    French ED; Vasquez SA; George R
    Eur J Pharmacol; 1979 Aug; 57(4):387-97. PubMed ID: 573695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
    Fdez Espejo E; Cador M; Stinus L
    Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.
    Dzoljic ED; Kaplan CD; Dzoljic MR
    Arch Int Pharmacodyn Ther; 1988; 294():64-70. PubMed ID: 3233054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral alterations produced by chronic naloxone injections.
    Malin DH; Layng MP; Swank P; Baker MJ; Hood JL
    Pharmacol Biochem Behav; 1982 Sep; 17(3):389-92. PubMed ID: 6890681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze.
    Zhang Z; Schulteis G
    Pharmacol Biochem Behav; 2008 May; 89(3):392-403. PubMed ID: 18308382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-administration of morphine in the cat.
    Kilbey MM; Ellinwood EH
    Int J Addict; 1980 Apr; 15(3):447-60. PubMed ID: 7189749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.
    Higgins GA; Nguyen P; Joharchi N; Sellers EM
    Psychopharmacology (Berl); 1991; 105(3):322-8. PubMed ID: 1839177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermoregulatory responses of the unrestrained cat to acute and chronic intravenous administration of low doses of morphine and to naloxone precipitated withdrawal.
    French ED; Vasquez SA; George R
    Life Sci; 1978 Jun; 22(21):1947-54. PubMed ID: 566833
    [No Abstract]   [Full Text] [Related]  

  • 9. Conditioned withdrawal in environments associated with the presence or absence of morphine.
    Schnur P; Wainwright M
    Pharmacol Biochem Behav; 1992 Mar; 41(3):543-6. PubMed ID: 1584832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An electromyographic method for the assessment of naloxone-induced abstinence in morphine-dependent rats.
    Menon MK; Tseng LF; Loh HH; Clark WG
    Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):43-9. PubMed ID: 7190227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracisternal administration of interleukin-1 beta attenuates naloxone-precipitated withdrawal in morphine-dependent mice.
    Katsumata S; Minami M; Nakagawa T; Satoh M
    Eur J Pharmacol; 1995 May; 278(2):143-50. PubMed ID: 7671998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enkephalinase inhibition suppresses naloxone-induced jumping in morphine-dependent mice.
    Dzoljic MR; Rademaker B; vd Poel-Heisterkamp AL; Ukponmwan OE; Haffmans J
    Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):222-8. PubMed ID: 3539055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR; Jones BC; Schulteis G
    Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
    Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats.
    Maldonado R; Valverde O; Derrien M; Tejedor-Real P; Roques BP
    Pharmacol Biochem Behav; 1994 Jun; 48(2):363-9. PubMed ID: 8090802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute morphine dependence in the hamster.
    Schnur P
    Pharmacol Biochem Behav; 1991 Apr; 38(4):711-3. PubMed ID: 1871187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of histaminergic-noradrenergic axis in naloxone-induced withdrawal symptoms in mice.
    el Kadi AO; Sharif SI
    Pharmacol Biochem Behav; 1996 Sep; 55(1):49-54. PubMed ID: 8870037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acoustic startle response as a measure of behavioral dependence in rats.
    Mansbach RS; Gold LH; Harris LS
    Psychopharmacology (Berl); 1992; 108(1-2):40-6. PubMed ID: 1410145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.